Your email has been successfully added to our mailing list.

×
0.215277777777778 0.215277777777778 0.215277777777778 0.215277777777778 0.215277777777778 0.215277777777778 0.118923611111111 0.0368923611111112
Stock impact report

NephroGenex to Present at BioEquity Europe 2014 Conference

NEPHROGENEX (NRX) 
Company Research Source: Business Wire
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Pierre Legault, Chief Executive Officer, will present a corporate overview at the 15th annual BioEquity Europe conference at the Hilton Amsterdam Hotel in Amsterdam. Mr. Legault will present from 3:20 – 3:40 PM CEST on Thursday, May 22, 2014 in Ballroom C. Pyridorin is the Company’s product candidate for the treatment of diabetic nephropathy—a chronic, degenerative disease of the kidney for which there are few therapeutic options. NephroGenex received Fast Track designation and a Special Protocol Assessment from FDA for Pyridorin, and is preparing to launch its pivotal, Phase 3 trial in patients with diabetic nephropathy in the next several months. BioEquity Europe is an industry-sponsored event fo Show less Read more
Impact Snapshot
Event Time:
NRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NRX alerts
Opt-in for
NRX alerts

from News Quantified
Opt-in for
NRX alerts

from News Quantified